The most recent guest on First Rounders is Grace Colón, president and CEO of InCarda Therapeutics. She did her graduate work at MIT, where she was mentored by Greg Stephanopoulos and Anthony Sinskey, and then went to work at McKinsey & Co. That began her career path toward biotech, including stints at Affymetrix (later bought by Thermo Fisher), and Gilead Sciences (currently doing its part against covid19).
She also has experience in venture capital, having been with New Science Ventures. The podcast can be found here.
Please sign in or register for FREE
If you are a registered user on Nature Portfolio Bioengineering Community, please sign in